Serum AGE-elastin derived peptides among diabetic children

Vascular Pharmacology

Volumn 43, Issue 4, 2005, Pages 193-197

  Nicoloff, G ^a   Nikolov, A ^a   Dekov, D ^a  

^a MEDICAL UNIVERSITY PLEVEN   (Bulgaria)

Author keywords

AGE elastin; Diabetes mellitus; Diabetic vascular complications

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALPHA ELASTIN; ELASTIN; HEMOCYANIN; PROTEIN DERIVATIVE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYDROLYSIS; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; RABBIT; SCHOOL CHILD; SHEEP; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; BLOOD PRESSURE; CHILD; DIABETES MELLITUS, TYPE 1; ELASTIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; IMMUNOGLOBULIN G; MALE; PEPTIDES; TRIGLYCERIDES;

EID: 27744449651     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2005.03.007     Document Type: Article

References (48)

1. G. Bako, M.P. Jacob, T. Fulop, G. Foris, A. Leovey, and L. Robert Immunology of elastin: study of anti-elastin peptide antibodies by DOT immunobinding assay Immunol. Lett. 15 1987 187 192
2. S. Baydanoff, G. Nicoloff, and Ch. Alexiev Age-related changes in the level of circulating elastin-derived peptides in serum from normal and atherosclerotic subjects Atherosclerosis 66 1987 163 168
3. S. Baydanoff, E. Konova, E. Dosheva, and P. Dorovski Non-enzymatic glycation of elastin Glycosyl. Dis. 1 1994 53 58
4. S. Baydanoff, E. Konova, and N. Ivanova Determination of anti-AGE antibodies in human serum Glucoconjug. J. 13 1996 335 339
5. J. Bignon, and L. Robert Les functions metaboliques du poumon: IV. Aspects biologiques et biochimiques actuels de l'emphyseme pulmonaire Rev. Med. 19 1978 764 778
6. L. Bizbiz, A. Alperovitch, and L. Robert Aging of the vascular wall-serum concentration of elastin peptides and elastase inhibitors in relation to the cardiovascular risk factor-the EVA study Atherosclerosis 131 1997 73 78
7. H. Bouissou, M.T. Pieraggi, M. Julian, and L. Douste Blazy Cutaneous aging. Its relation with atherosclerosis and atheroma L. Robert B. Robert Front. Matrix Biol. vol. 1 1973 Karger Basel 190 211
8. H. Bouissou, M.T. Pieraggi, and M. Julian Aging of elastic tissue in skin and arteries L. Robert K. Murata Y. Nagai Degenerative Diseases of Connective Tissue and Aging 1985 Kodansha Tokyo 203 216
9. B.M. Brenner, T.H. Hostetter, and H.D. Humes Molecular basis of proteinuria of glomerular origin N. Engl. J. Med. 298 1978 826 833
10. M. Brownlee Glycation and diabetic complications Diabetes 43 1994 836 841
11. M. Brownlee, A. Cerami, and H. Vlassara Advanced glycation end products in tissue and the biochemical basis of diabetic complications N. Engl. J. Med. 318 1988 1315 1321
12. C.S. Cox Roles of Maillard Reactions in Diseases 1991 HMSO London
13. C. Frances, and L. Robert Elastin and elastic fibers in normal and pathological skin Int. J. Dermatol. 23 1984 166 179
14. T. Fulop, S.M. Wei, L. Robert, and M.P. Jacob Determination of elastin peptides in normal and atherosclerotic human sera by ELISA Clin. Physiol. Biochem. 8 1990 273 282
15. T. Fulop, M.P. Jacob, A. Khalil, J. wallach, and L. Robert Biological effects of elastin peptides Pathol. Biol. 46 1998 497 506
16. H.P. Hammes, A. Weiss, S. Hess, N. Araki, S. Horiuchi, M. Brownlee, and T. Preissner Modification of vitronectin by advanced glycation alters functional properties in vitro and in diabetic retina Lab. Invest. 75 1996 325 338
17. F. Hayase, R.H. Nagaraj, S. Miyata, F.G. Njoroge, and V.M. Monnier Aging of proteins: immunological detection of a glucose-derived pyrrole formed during Maillard reaction in vivo J. Biol. Chem. 263 1989 3758 3764
18. M. Holzenberger, S.A. Leviinzi, C.P. Herzog, S.B. Deak, L. Robert, and C.D. Boyd Quantitation of tropoelastin messenger RNA and assessment of alternative splicing in human skin fibroblasts by reverse transcriptase polymerase chain reaction PCR Methods Appl. 3 1993 107 114
19. S. Horiuchi, N. Araki, and Y. Morino Immunological approach to characterize advanced glycation end products of the Maillard reaction. Evidence for the presence of a common structure J. Biol. Chem. 266 1991 7329 7332
20. W. Hornebeck, D. Brechemier, M.P. Jacob, C. Frances, and L. Robert On the multiplicity of cellular elastases and their inefficient control by natural inhibitors Horl Heidland Proteases: Potential Role in Health and Disease Adv. Exp. Med. Biol. vol. 167 1984 Plenum Press New York 111 119
21. R. Ikan The Maillard Reaction. Consequences for the Chemical and Life Sciences 1996 John Wiley and Sons Chichester, UK
22. M.P. Jacob, T. Fulop, G. Foris, and L. Robert Effect of elastin peptides on ion fluxes in mononuclear cells, fibroblasts and smooth muscle cells Proc. Natl. Acad. Sci. U. S. A. 84 1987 995 999
23. L. Kennedy Glycation of immunoglobulins and serum proteins K.G.M.M. Alberti R.A. de Fronzo H. Keen P. Zimmet International Textbook of Diabetes Mellitus 2nd edition 1992 John Wiley Chichester 985 1007
24. H. Makino, K. Schikata, and K. Hironaka Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy Kidney Int. 48 1995 517 526
25. Z. Makita, H. Vlassara, A. Cerami, and R. Bucala Immunochemical detection of advanced glycosylation end products in vivo J. Biol. Chem. 267 1992 5133 5138
26. M. Medof, and J. Oger Competitions for immune complexes by red cells in human blood J. Clin. Lab. Immunol. 7 1982 7 13
27. Microalbuminuria Collaborative Study Group United Kingdom Risk factors for development of microalbuminuria in insulin dependent diabetic patients: a cohort study: Microalbuminuria Collaborative Study Group, U.K. BMJ 306 1993 1235 1239
28. H.B. Mortensen, P. Poulgaard Hvidore Study Group on Childhood Diabetes Comparison of metabolic control in a cross-sectional study of 2.873 children and adolescents with IDDM from 18 countries Diabetes Care 20 1997 714 720
29. T. Murata, R. Nagai, T. Ishibashi, H. Inomata, K. Ikeda, and S. Horiuchi The relationship between accumulation of advanced glycation end products and expression of vascular endothelial growth factor in human diabetic retinas Diabetologia 40 1997 764 769
30. G. Nicoloff, S. Baydanoff, N. Stanimirova, Ch. Petrova, and P. Christova Relationship between elastin-derived peptides and the development of diabetic microvascular complications-a longitudinal study in children with Type 1 (insulin-dependent) diabetes mellitus Gen. Pharmacol. 35 2000 59 64
31. G. Nicoloff, S. Baydanoff, N. Stanimirova, Ch. Petrova, and P. Christova An association of anti-elastin IgA antibodies with development of retinopathy in diabetic children Gen. Pharmacol. 35 2000 83 87
32. G. Nicoloff, S. Baydanoff, Ch. Petrova, and P. Christova Antibodies to advanced glycation end products in children with diabetes mellitus Vasc. Pharmacol. 39 2002 39 45
33. P. Poulsen, K. Hansen, and C. Mogensen Ambulatory blood pressure in the transition from normo- to microalbuminuria. A longitudinal study in IDDM patients Diabetes 43 1994 1248 1253
34. L. Robert Mechanisms of aging of the extracellular matrix. Role of the elastin-laminin receptor, Novartis Price Lecture Gerontology 44 1998 307 317
35. L. Robert, and W. Hornebeck Elastin and Elastases: I and II 1989 CRS Press Boca Raton, Florida
36. L. Robert, and J. Labat-Robert Aging of connective tissues: from genetic to epigenetic mechanisms Biogereontology 1 2000 123 131
37. L. Robert, and A.M. Robert Elastin, elastase and arteriosclerosis L. Robert A.M. Robert Biology and Pathology of Elastic Tissues Front. Matrix Biol. vol. 8 1980 Basel Karger 130 173
38. L. Robert, J. Chaudiere, and B. Jacotot Interaction between lipids and the intercellular matrix of the arterial wall: its role in the evolution of atherosclerotic lesions Malinow Blaton Regression of Atherosclerotic Lesions-Experimental Studies and Observations in Humans NATO ASI Series. Life Sciences vol. 79 1984 Plenum Press New York 145
39. L. Robert, C. Lesty, and A.M. Robert Ageing of the skin: study of elastic fiber network. Modifications by computerized image analysis Gerontology 34 1988 291 296
40. L. Robert, M.P. Jacob, T. Fulop, J. Timar, and W. Hornebeck Elastonectin and the elastin receptor Pathol. Biol. 37 1989 736 741
41. R. Senior, G. Griffin, and R. Mecham Chemotactic activity of elastin derived peptides J. Clin. Invest. 66 1980 859 862
42. R. Singh, A. Barden, T. Mori, and L. Beilin Advanced glycation end-products: a review Diabetologia 44 2001 129 146
43. P.J. Stone Potential use of collagen and elastin degradation markers for monitoring liver fibrosis in schistosomiasis Acta Trop. 77 2000 97 99
44. M.R. Taskinen Diabetic dyslipidaemia: from basic research to clinical practice Diabetologia 46 2003 733 749
45. Z. Turk, S. Ljubic, N. Turk, and B. Benko Detection of autoantibodies against advanced glycation endproduct and AGE-immune complexes in serum of patients with diabetes mellitus Clin. Chim. Acta 303 2001 105 115
46. Z. Turk, M. Sesto, J. Scodlar, G. Ferencak, R. Pokupec, N. Turk, and A. Stavljenic-Rukavina Products of advanced glycation in patients with type 2 diabetes and vascular disease Ann. Clin. Biochem. 40 2003 552 559
47. H. Vlassara, R. Bucala, and L. Striker Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging Lab. Invest. 70 1994 138 151
48. C. Winlove, K. Parker, N. Avery, and A. Bailey Interactions of elastin and aorta with sugars in vitro and their effects on biochemical and physical properties Diabetologia 39 1996 1131 1139